Psychological Benefits of Camping in Treating Children With Cancer - Full Text View

Sponsor:	National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00018915

Purpose

RATIONALE: Children with cancer who go camping with other patients may have improved quality of life, self-esteem, and relationships with parents, family, and peers.

PURPOSE: Clinical trial to study the psychological benefits of a 1-week camping trip for children with cancer.

Condition	Intervention
Psychosocial Effects of Cancer and Its Treatment Unspecified Childhood Solid Tumor, Protocol Specific	Procedure: psychosocial assessment and care Procedure: quality-of-life assessment

Study Type:	Interventional
Official Title:	Psychological Benefits of a "Normalized" Camping Experience for Children With Cancer

Resource links provided by NLM:

MedlinePlus related topics: Cancer

U.S. FDA Resources

Further study details as provided by National Cancer Institute (NCI):

Estimated Enrollment:	9999
Study Start Date:	March 1983

Detailed Description:

OBJECTIVES:

Determine whether quality of life, particularly sense of well being, self-esteem, and relationships with parents, family, and peers, improves in children with cancer who participate in an enriched, normalized camping experience.
Determine whether professional or volunteer caregivers improve the quality of their interrelations with this patient population after participating in an enriched, normalized camping experience.

OUTLINE: Patients participate in a full range of age appropriate activities and undergo observation during an enriched, normalized camping experience for 1 week. Patients and their family members undergo psychosocial interviews and patients complete psychological questionnaires before, during, and after the camping experience. Medical care continues to be provided according to the plan formulated between the patient's home medical team and the NIH-based medical team.

Quality of life is assessed.

PROJECTED ACCRUAL: Approximately 9,999 patients will be accrued for this study.

Eligibility

Ages Eligible for Study:	7 Years to 17 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Diagnosis of cancer
- Currently receiving treatment OR
- No more than 3 years since prior treatment OR
Young adults with cancer acting as camp counselors

PATIENT CHARACTERISTICS:

Age:

7 to 17

Performance status:

Not specified

Life expectancy:

Not specified

Hematopoietic:

Not specified

Hepatic:

Not specified

Renal:

Not specified

Other:

Concurrent physical defects allowed

PRIOR CONCURRENT THERAPY:

Biologic therapy:

Concurrent blood products allowed

Chemotherapy:

Not specified

Endocrine therapy:

Not specified

Radiotherapy:

Not specified

Surgery:

Prior amputations allowed

Other:

Concurrent intramuscular, intrathecal, oral, or IV medications allowed

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018915

Locations

United States, Maryland
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office	Recruiting
Bethesda, Maryland, United States, 20892-1182
Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937

Sponsors and Collaborators

National Cancer Institute (NCI)

Investigators

Study Chair:

Stephen J. Chanock, MD

National Cancer Institute (NCI)

More Information

Additional Information:

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	CDR0000074606, NCI-83-C-0022F, NCI-T83-1094N
Study First Received:	July 11, 2001
Last Updated:	August 19, 2009
ClinicalTrials.gov Identifier:	NCT00018915 History of Changes
Health Authority:	Unspecified

Keywords provided by National Cancer Institute (NCI):

unspecified childhood solid tumor, protocol specific
psychosocial effects of cancer and its treatment

ClinicalTrials.gov processed this record on November 27, 2009